REBECCA WALDECK: Open Payments
NPI 1013410745 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$680 in 23 payments from 12 companies in 2025. Trend: 2023 $191 · 2024 $455 · 2025 $680
Food & beverage: $680
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 2 | $281 |
| AstraZeneca Pharmaceuticals LP | 5 | $88 |
| Merck Sharp & Dohme LLC | 3 | $59 |
| Novartis Pharmaceuticals Corporation | 3 | $57 |
| GENZYME CORPORATION | 2 | $45 |
| Daiichi Sankyo Inc. | 2 | $42 |
| Alexion Pharmaceuticals, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $21 |
| Janssen Biotech, Inc. | 1 | $19 |
| Ipsen Biopharmaceuticals, Inc | 1 | $16 |
Products named: SYNCHROMEDII, PLUVICTO, KEYTRUDA, Enhertu, LYNPARZA, ULTOMIRIS, IMBRUVICA, SARCLISA.
Industry payments across OH — which companies pay providers there.
